APA (7th ed.) Citation

PM, F., KJ, W., RC, C., J, P., CX, M., MJ, E., . . . H, P. (2011). A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. Cancer chemotherapy and pharmacology, 67(6), 1225. https://doi.org/10.1007/s00280-010-1410-1

Chicago Style (17th ed.) Citation

PM, Fracasso, et al. "A Phase 1 Study of UCN-01 in Combination with Irinotecan in Patients with Resistant Solid Tumor Malignancies." Cancer Chemotherapy and Pharmacology 67, no. 6 (2011): 1225. https://doi.org/10.1007/s00280-010-1410-1.

MLA (9th ed.) Citation

PM, Fracasso, et al. "A Phase 1 Study of UCN-01 in Combination with Irinotecan in Patients with Resistant Solid Tumor Malignancies." Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, 2011, p. 1225, https://doi.org/10.1007/s00280-010-1410-1.